Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jerash Holdings (US) (JRSH) EBITDA (2016 - 2025)

Historic EBITDA for Jerash Holdings (US) (JRSH) over the last 10 years, with Q4 2025 value amounting to $1.2 million.

  • Jerash Holdings (US)'s EBITDA rose 93502.16% to $1.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 million, marking a year-over-year increase of 14602.85%. This contributed to the annual value of -$869172.0 for FY2025, which is 6395.0% up from last year.
  • Per Jerash Holdings (US)'s latest filing, its EBITDA stood at $1.2 million for Q4 2025, which was up 93502.16% from $462088.0 recorded in Q3 2025.
  • Over the past 5 years, Jerash Holdings (US)'s EBITDA peaked at $4.4 million during Q3 2021, and registered a low of -$3.5 million during Q1 2024.
  • Moreover, its 5-year median value for EBITDA was $431977.5 (2023), whereas its average is $480941.8.
  • In the last 5 years, Jerash Holdings (US)'s EBITDA soared by 144573.5% in 2021 and then tumbled by 165953.4% in 2023.
  • Over the past 5 years, Jerash Holdings (US)'s EBITDA (Quarter) stood at $1.7 million in 2021, then plummeted by 45.92% to $928622.0 in 2022, then plummeted by 64.32% to $331341.0 in 2023, then crashed by 144.3% to -$146775.0 in 2024, then soared by 935.02% to $1.2 million in 2025.
  • Its EBITDA stands at $1.2 million for Q4 2025, versus $462088.0 for Q3 2025 and $333194.0 for Q2 2025.